Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gero Knittel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Cell Reports|October 26, 2018
The Cdkn1a<sup>SUPER</sup> Mouse as a Tool to Study p53-Mediated Tumor SuppressionAlessandro Torgovnick, Jan Michel Heger, Vasiliki Liaki, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Cancer Cell|August 22, 2025
Lymphoma accelerates T cell and tissue agingRebecca S Hesterberg, Joshua T Davis, Komal J Handoo, et al.
Blood|April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesisKristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Cell Reports|October 26, 2018
The Cdkn1a<sup>SUPER</sup> Mouse as a Tool to Study p53-Mediated Tumor SuppressionAlessandro Torgovnick, Jan Michel Heger, Vasiliki Liaki, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Cancer Cell|August 22, 2025
Lymphoma accelerates T cell and tissue agingRebecca S Hesterberg, Joshua T Davis, Komal J Handoo, et al.
Blood|April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesisKristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Blood|February 4, 2021
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1Vivien Kohlhaas, Stuart James Blakemore, Mona Al-Maarri, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Pageof 4